These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 216767)

  • 41. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural human antibodies reactive with primate type-C viral antigens.
    Kurth R; Teich NM; Weiss R; Oliver RT
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1237-41. PubMed ID: 191833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma.
    Nunn ME; Djeu JY; Glaser M; Lavrin DH; Herberman RB
    J Natl Cancer Inst; 1976 Feb; 56(2):393-9. PubMed ID: 1082939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera.
    Hino S; Stephenson JR; Aaronson SA
    J Virol; 1976 Jun; 18(3):933-41. PubMed ID: 58081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cell-mediated microcytotoxicity and stimulation of mixed lymphocyte reactivity by mouse pregnancy serum.
    Smith G
    Transplantation; 1978 Nov; 26(5):278-83. PubMed ID: 151950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 49. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
    Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
    Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elicitation of primary anti-Sendai virus cytotoxic T lymphocytes with purified viral glycoproteins.
    McGee M; Hale AH; Panetti M
    Eur J Immunol; 1980 Dec; 10(12):923-8. PubMed ID: 6258925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
    Plata F; Tilkin AF; Lévy JP; Lilly F
    J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural antibodies in human sera cross-reactive with type C RNA tumor viral P 30.
    Herbrink P; van Bussel FJ; Warnaar SO
    Anticancer Res; 1982; 2(5):291-6. PubMed ID: 6299171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.
    Balachandran N; Seth P; Mohapatra LN
    Infect Immun; 1980 Sep; 29(3):846-52. PubMed ID: 7000705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demonstration of different glycosylated antigens in C-type virus-transformed and infected rat cells by antiserum to murine leukemia virus.
    Rieber M; Bacalao J; Rieber M; Alonso G
    Cancer Res; 1977 Apr; 37(4):1165-9. PubMed ID: 191179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of murine leukemia viral antigens detected on mouse cells by H-2 alloantisera.
    Milner RJ; Henning R; Edelman GM
    Eur J Immunol; 1976 Sep; 6(9):603-7. PubMed ID: 187431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC; Ihle JN; Huebner R
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoglobulin and other surface antigens of cells of the immune system.
    Takahashi T; Old LJ; McIntire KR; Boyse EA
    J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.